Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
23 Mar 2020
Survey Results Reveal Need for Earlier Diagnosis of Liver Disease
THE LARGEST survey of liver disease patients in the UK has revealed that half of the respondents did not exhibit symptoms prior to their diagnosis…
23 Mar 2020
Could Aspirin Reduce Risk of Liver Cancer in Viral Hepatitis?
ASPIRIN could be an effective therapy in reducing the risk of liver cancer and liver-related death in patients with chronic viral…
4
Mins
24 Feb 2020
New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism
Aramchol is a liver-targeted, oral stearoyl coenzyme A desaturase 1 (SCD1) modulator that has been shown to reduce liver fat and fibrosis in patients…
18 Dec 2019
Positive Outcomes from Minimum Alcohol Pricing in Scotland
MINIMUM unit pricing (MUP) was first introduced in Scotland in 2018, raising the price per unit of alcohol to 50p. Now, experts…
18 Dec 2019
Phage Therapy Shows Potential in Treating Alcoholic Liver Disease
BACTERIOPHAGES have been used to successfully treat alcoholic liver disease in mice in a recent study…
17 Dec 2019
The News is all Good about Hepatitis C
I should not be alive to write this. It took a medical miracle, the world’s first ever cure for a virus, and some close timing. It also took me pushing…
12
Mins
12 Dec 2019
A Review of Liver Fibrosis and Emerging Therapies
With the increasing burden of liver cirrhosis, the most advanced stage of hepatic fibrosis, there is a need to better understand the pathological…
9
Mins
6 Nov 2019
Hepatitis B Care Pathway in the United Arab Emirates: Current Situation, Gaps, and Actions
This paper aims to assess the current situation of the HBV care pathway in the United Arab Emirates (UAE), identify gaps and barriers therein…
Loading posts...
« Previous
1
…
49
50
51
52
53
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View